<DOC>
	<DOCNO>NCT01667367</DOCNO>
	<brief_summary>This single-center , single-blind , placebo-controlled , parallel-group study crossover component evaluate GABAAalpha5 receptor expression , occupancy functional connectivity brain individual Down syndrome healthy control follow single dose RG1662 . Participants receive single dose placebo image session ( PET MRI ) , single dose RG1662 second imaging session .</brief_summary>
	<brief_title>A Molecular Functional Brain Imaging Study Individuals With Down Syndrome Healthy Controls Following Single Dose RG1662</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Down Syndrome</mesh_term>
	<criteria>Healthy control individual Down syndrome : Male female adult , 18 40 year age Body mass index ( BMI ) 18 40 kg/m2 inclusive Females childbearing potential male female partner childbearing potential must agree use two medically approve method contraception , one must barrier method , duration study 4 month last study drug administration Clinical laboratory value within normal limit abnormality consider significant investigator sponsor ; individual thyroid disease may include study provide euthyroid stable treatment least one month prior screen Individuals Down syndrome must also meet follow : Diagnosis Down syndrome confirm karyotype ; subject may free trisomy 21 Robertsonian translocation ; mosaic Down syndrome exclude Individuals must parent reliable caregiver agree accompany inidvidual clinic visit , provide information individual require protocol , willing give inform consent Regular smoker ( &gt; 5 cigarette equivalent : 3 cigar , 6 cigarillo , 3 pipe per day ) Concomitant disease condition clinically significant find screening could interfere , treatment might interfere conduct study , would , opinion investigator , pose unacceptable risk subject study Severe head trauma CNS infection ( e.g . meningitis ) History epilepsy seizures benign febrile convulsion childhood Any confirmed significant allergic reaction drug , anaphylaxis severe environmental allergy judge investigator Positive hepatitis B , hepatitis C HIV infection Positive urine test screen followup drug abuse , positive alcohol breath test screen prior dose Previous inclusion research and/or medical protocol involve nuclear medicine , PET radiological investigation significant radiation burden ( define protocol ) Pregnant lactate woman Individuals evidence meeting clinical diagnosis dementia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>